ArticleZoonoses and public health2026
Serological and Molecular Surveillance of Influenza A Virus in Dogs and Cats in Central Chile.
Article in Zoonoses and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionInfluenza A virus (IAV) is a zoonotic pathogen with pandemic potential that infects a wide range of species, including companion animals. Although surveillance efforts have primarily focused on North America, Europe and Asia, data from South America remain scarce. This study evaluated the molecular and serological evidence of IAV circulation in dogs and cats from shelters and multi-pet households in central Chile.
methodsBetween June and November 2020, oropharyngeal swabs and serum samples were collected from dogs and cats in shelters and multi-pet households in central Chile. Samples were analysed by RT-qPCR, NP-ELISA and hemagglutination inhibition assay.
resultsIAV was detected by RT-qPCR in 3.2% (11/342) of dogs (95% CI: 1.3%-5.1%) and 5.8% (4/69) of cats (95% CI: 0.3%-11.3%). Serological analysis revealed IAV seropositivity in 55.5% (96/173) of dogs (95% CI: 48.1%-62.9%) and 50.0% (10/20) of cats (95% CI: 28.1%-71.9%). Additionally, pdmH1N1 antibodies were detected in 26 animals (25.7%; 95% CI: 17.2%-34.2%) out of 101 NP-ELISA-positive serum samples, with higher median titres for cats (median = 160) compared to dogs (median = 20). Low-level antibody titres against Canine/H3N2 (range = 10-20) were identified in three dogs (3.0%; 95% CI: 0.0%-6.3%), whereas no antibodies were detected against Canine/H3N8 or Avian/H3N6. No significant associations were observed between seropositivity and animal age, sex, origin or area.
conclusionsThis study presents the first report of IAV detection in cats in South America and highlights a high level of IAV exposure among companion animals in central Chile. These findings underscore the importance of including pets in IAV surveillance efforts under a One Health approach and highlight the need for expanded monitoring and genetic characterization of circulating strains to assess zoonotic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.